Synovus Financial Corp Merck & Co., Inc. Transaction History

Synovus Financial Corp

$9.33 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 324,981 shares of MRK stock, worth $32 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

324,981

Previous 298,532 8.86%

Holding current value

$32 Million

Previous $37 Million 0.15%

% of portfolio

0.4%

Previous 0.49%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $2.94 Million - $3.41 Million	26,449 Added 8.86%	324,981 $36.9 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $861,895 - $925,667	-6,962 Reduced 2.28%	298,532 $37 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $11.3 Million - $13.2 Million	-99,870 Reduced 24.64%	305,494 $40.3 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $1.46 Million - $1.62 Million	-14,195 Reduced 3.38%	405,364 $41.7 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $30,084 - $32,791	277 Added 0.07%	419,559 $48.4 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $322,613 - $359,971	-3,134 Reduced 0.74%	419,282 $44.6 Million
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $401,961 - $515,369	4,597 Added 1.1%	422,416 $46.9 Million
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $938,705 - $1.05 Million	11,105 Added 2.73%	417,819 $36 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $1.62 Million - $1.84 Million	19,440 Added 5.02%	406,714 $37.1 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $3.21 Million - $3.6 Million	-43,708 Reduced 10.14%	387,274 $31.7 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $8.9 Million - $11.1 Million	123,067 Added 39.97%	430,982 $33 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $1.85 Million - $2.03 Million	-25,774 Reduced 7.72%	307,915 $23.2 Million
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $6.8 Million - $7.53 Million	-96,781 Reduced 22.48%	333,689 $26 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $784,108 - $923,599	11,387 Added 2.72%	430,470 $33.2 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $1.01 Million - $1.13 Million	14,127 Added 3.49%	419,083 $34.2 Million
Q3 2020 Nov 09, 2020	SELL	$73.18 - $82.95 $733,556 - $831,490	-10,024 Reduced 2.42%	404,956 $33.6 Million
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $5.53 Million - $6.29 Million	-78,490 Reduced 15.91%	414,980 $32.1 Million
Q1 2020 Apr 24, 2020	BUY	$63.36 - $87.82 $6.7 Million - $9.29 Million	105,733 Added 27.27%	493,470 $38 Million
Q4 2019 Feb 06, 2020	SELL	$77.58 - $87.54 $57,176 - $64,516	-737 Reduced 0.19%	387,737 $35.3 Million
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $905,352 - $986,867	11,900 Added 3.16%	388,474 $32.7 Million
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $648,115 - $757,155	-9,280 Reduced 2.41%	376,574 $31.6 Million
Q1 2019 May 09, 2019	SELL	$69.58 - $79.36 $146,674 - $167,290	-2,108 Reduced 0.54%	385,854 $32.1 Million
Q4 2018 Feb 07, 2019	SELL	$65.24 - $75.71 $3.57 Million - $4.15 Million	-54,792 Reduced 12.38%	387,962 $29.7 Million
Q3 2018 Nov 01, 2018	SELL	$57.69 - $67.84 $696,837 - $819,439	-12,079 Reduced 2.66%	442,754 $31.4 Million
Q2 2018 Aug 01, 2018	BUY	$50.83 - $59.72 $254,353 - $298,838	5,004 Added 1.11%	454,833 $27.6 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $360,083 - $418,519	7,066 Added 1.6%	449,829 $24.5 Million
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $948,672 - $1.13 Million	18,378 Added 4.33%	442,763 $24.9 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $24.9 Million - $26.8 Million	424,385	424,385 $27.2 Million

Others Institutions Holding MRK

# of Institutions

3,814

Shares Held

1.88B

Call Options Held

14.6M

Put Options Held

13.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Merck & Co., Inc. Transaction History